An Oxford spinout raises $44M as it looks to resurrect an old Roche antibody in pursuit of a rare disease
Three months ago, a small and little-known Oxford University spinout called Celleron announced they would try to resurrect an antibody Roche retired back in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
